Suzuki Ryoko, Watanabe Hideomi, Yanagawa Takashi, Sato Junko, Shinozaki Tetsuya, Suzuki Hideki, Endo Keigo, Takagishi Kenji
Department of Orthopedic Surgery, Gunma University Graduate School of Medicine, Japan.
Ann Nucl Med. 2005 Dec;19(8):661-70. doi: 10.1007/BF02985114.
The relative utility of various preoperative diagnostic imaging modalities, including PET (utilizing FDG and FMT), CT, and MR imaging, for evaluation of lipoma and liposarcoma, especially well-differentiated liposarcoma, was investigated.
Imaging findings in 32 patients with histopathologically documented lipoma, including one with fibrolipoma and one with angiolipoma, and 25 patients with liposarcomas whose subtypes included 10 well-differentiated, 10 myxoid, and 5 other types were reviewed retrospectively. Pre-operative imaging included FDG-PET (n = 44), FMT-PET (n = 21), CT (n = 25), and MR imaging (n = 53).
Statistically significant imaging features of MR images favoring a diagnosis of liposarcoma involved lesions containing less than 75% fat (p < 0.001) as well as the presence of septa (p < 0.001). As compared with well-differentiated liposarcoma, benign lesions were differentiated significantly only by the presence of septa (p < 0.001), which also provided significant differentiation on CT (p < 0.05). The mean SUVs for malignant tumors were significantly higher than those for benign lesions in both FDG- and FMT-PET analyses (p < 0.0001, p = 0.0011, respectively). By using a cut-off value for FDG- and FMT-PET set at 0.81 and 1.0 respectively, which provided the highest accuracy, benign lesions were differentiated significantly from liposarcomas (p < 0.001, and p < 0.02). Furthermore, benign tumors and the three subtypes of liposarcoma were divided significantly into four biological grades by FDG- and FMT-accumulation rates (rho = 0.793, p < 0.0001; and rho = 0.745, p = 0.0009, respectively). A cut-off value of 0.81 for FDG-PET provided significant differentiation between benign lesions and well-differentiated liposarcoma (p < 0.01).
The presence of septa on MR images differentiated lipomas from liposarcoma, even well-differentiated type. PET analysis, especially FDG-PET, quantitatively provided not only the differentiation but also the metabolic separation among subtypes of liposarcoma. Interpretation of the visual diagnostic modalities requires extensive experience and carries a risk of ignoring a critical portion of malignancy. PET metabolic imaging may be an objective and useful modality for evaluating adipose tissue tumors preoperatively.
研究包括PET(利用FDG和FMT)、CT和MR成像在内的各种术前诊断成像方式对脂肪瘤和脂肪肉瘤,尤其是高分化脂肪肉瘤的评估的相对效用。
回顾性分析32例经组织病理学证实为脂肪瘤的患者(包括1例纤维脂肪瘤和1例血管脂肪瘤)以及25例脂肪肉瘤患者(其亚型包括10例高分化、10例黏液样和5例其他类型)的影像表现。术前成像包括FDG-PET(n = 44)、FMT-PET(n = 21)、CT(n = 25)和MR成像(n = 53)。
MR图像上支持脂肪肉瘤诊断的具有统计学意义的影像特征包括脂肪含量低于75%的病变(p < 0.001)以及存在分隔(p < 0.001)。与高分化脂肪肉瘤相比,良性病变仅通过存在分隔可显著区分(p < 0.001),这在CT上也有显著区分(p < 0.05)。在FDG-和FMT-PET分析中,恶性肿瘤的平均SUV均显著高于良性病变(分别为p < 0.0001,p = 0.0011)。通过分别将FDG-和FMT-PET的临界值设定为0.81和1.0,可提供最高准确性,良性病变与脂肪肉瘤可显著区分(p < 0.001和p < 0.02)。此外,根据FDG-和FMT-摄取率,良性肿瘤和脂肪肉瘤的三种亚型可显著分为四个生物学级别(分别为rho = 0.793,p < 0.0001;和rho = 0.745,p = 0.0009)。FDG-PET的临界值0.81可显著区分良性病变和高分化脂肪肉瘤(p < 0.01)。
MR图像上分隔的存在可将脂肪瘤与脂肪肉瘤区分开来,即使是高分化类型。PET分析,尤其是FDG-PET,不仅在定量上可区分脂肪肉瘤的亚型,还能进行代谢分离。视觉诊断方式的解读需要丰富经验,且存在忽略恶性关键部分的风险。PET代谢成像可能是术前评估脂肪组织肿瘤的一种客观且有用的方式。